Sylvette Lugo Cintron, MD | |
Hospital Metropolitano Dr. Tito Mattei, Carr.128 Km1.0, Yauco, PR 00698-0068 | |
(787) 856-1000 | |
(787) 856-0264 |
Full Name | Sylvette Lugo Cintron |
---|---|
Gender | Female |
Speciality | General Practice |
Experience | 21 Years |
Location | Hospital Metropolitano Dr. Tito Mattei, Yauco, Puerto Rico |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154304830 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 16098 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sylvette Lugo Cintron, MD Hc 2 Box 6458, Guayanilla, PR 00656-9607 Ph: (787) 927-7040 | Sylvette Lugo Cintron, MD Hospital Metropolitano Dr. Tito Mattei, Carr.128 Km1.0, Yauco, PR 00698-0068 Ph: (787) 856-1000 |
News Archive
Absorption Pharmaceuticals LLC in collaboration with Kaiser Permanente announced today the initiation of a clinical trial to evaluate the efficacy of Promescent lidocaine spray for men with premature ejaculation. This Phase III, double blind, placebo-controlled, randomized study will measure the intravaginal ejaculatory latency time for subjects aged 18 and older.
Areas with a high density of alcohol outlets have higher drink-related hospital admission rates, a new study from the University of Sheffield has found.
Business and healthcare leaders looking to fast-track preparedness for the H1N1 pandemic are gathering with infectious disease experts and Fortune 500 planners this month to determine how best to protect their employees and preserve their operations.
Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity of quizartinib, a small-molecule inhibitor of FLT3, and AC886, the active metabolite of quizartinib, compared with those of other FLT3 inhibitors.
Scientists at The Scripps Research Institute (TSRI) and the Salk Institute for Biological Studies have discovered how a mutant protein triggers nerve damage in a subtype of Charcot-Marie-Tooth (CMT) diseases, a group of currently untreatable conditions that cause loss of function in a person's hands and feet.
› Verified 2 days ago
Dr. Zahira Danelys Rivera Nazario, General Practice Medicare: Medicare Enrolled Practice Location: Hospital Pavia Yauco, Carr128 Km 1.0, Yauco, PR 00698 Phone: 787-856-1000 | |
Jonathan Felix, General Practice Medicare: Medicare Enrolled Practice Location: Callejon Hernandez, Yauco, PR 00698 Phone: 939-788-0349 | |
Gretchen Ortiz Sanchez, MD General Practice Medicare: May Accept Medicare Assignments Practice Location: #39 Calle Santo Domingo, Yauco, PR 00698 Phone: 787-856-4747 Fax: 787-992-7104 | |
Lorenia Delgado Pacheco, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: E7 Calle Padre Alfredo Vallina, Urb Costa Sur, Yauco, PR 00698 Phone: 787-630-6206 | |
Dr. Karen Rodriguez Rodriguez, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: Carretera 368 Km 12.1, Yauco, PR 00698 Phone: 787-856-1400 | |
Dr. Jose E. Castellon Miranda, General Practice Medicare: Accepting Medicare Assignments Practice Location: 71 Calle Comercio, Yauco, PR 00698 Phone: 787-856-0844 Fax: 787-267-5554 |